Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Retained Earnings: 2020-2024

Historic Retained Earnings for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to -$117.4 million.

  • Biofrontera's Retained Earnings fell 15.16% to -$133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$133.6 million, marking a year-over-year decrease of 15.16%. This contributed to the annual value of -$117.4 million for FY2024, which is 17.82% down from last year.
  • Biofrontera's Retained Earnings amounted to -$117.4 million in FY2024, which was down 17.82% from -$99.7 million recorded in FY2023.
  • Biofrontera's 5-year Retained Earnings high stood at -$41.2 million for FY2020, and its period low was -$117.4 million during FY2024.
  • In the last 3 years, Biofrontera's Retained Earnings had a median value of -$99.7 million in 2023 and averaged -$98.9 million.
  • Data for Biofrontera's Retained Earnings shows a maximum YoY plummeted of 91.45% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Biofrontera's Retained Earnings stood at -$41.2 million in 2020, then slumped by 91.45% to -$78.9 million in 2021, then decreased by 0.81% to -$79.5 million in 2022, then declined by 25.32% to -$99.7 million in 2023, then fell by 17.82% to -$117.4 million in 2024.